As pharma companies bolster their pipelines via multibillion-dollar acquisitions, drug manufacturers continue to heavily invest in the oncology space.
The rapid study startup process can ensure studies are finely tuned for scientific validity.
Drug companies have brought a host of expensive new medicines to market in the United States and Europe this year, figures show, another bumper haul for an industry often accused of over-charging. Drug prices are set to be a major issue in the run-up to the U.S. presidential election next year, with Democratic candidate Hillary […]
PHILADELPHIA, Aug. 4, 2015 /PRNewswire/ — The Intellectual Property and Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals announced the release of the 2015 CMR Pharmaceutical R&D Factbook, the biopharmaceutical industry’s leading resource of global R&D trends. Despite concerns around declines in R&D, the analysis identifies a surge […]
July 30, 2015By Alex Keown, BioSpace.com Breaking News Staff Over the last few weeks, we asked our readers a number of questions about the Garden State’s attractiveness as a site for corporate headquarters or research facilities. New Jersey, the BioSpace community said, will continue to maintain a strong position as a hub of biotech and […]